Scarica l'app Stockscreener
0.60
0.00%
0.00
Dopo l'orario di chiusura:
.60
VolitionRX Ltd Borsa (VNRX) Ultime notizie
VolitionRx (NYSE:VNRX) Now Covered by StockNews.com - Defense World
VolitionRx (NYSE:VNRX) Now Covered by Analysts at StockNews.com - Defense World
Volition to share new 'NETs in sepsis management' data insights at upcoming webinar - Quantisnow
VolitionRx adds Dr. Ethel Rubin to its board By Investing.com - Investing.com South Africa
VolitionRx adds Dr. Ethel Rubin to its board - Investing.com India
Volition Appoints Dr. Ethel Rubin as an Independent Director - Quantisnow
VolitionRx announces executive employment updates - Investing.com India
Agency News | ⚡Tamil Nadu’s Veterinary Varsity Directed by High Court To Consider Transgender Student’s Application - LatestLY
Madras HC directs TN veterinary varsity to not reject transgender's application over identity - Hindustan Times
Madras High Court Orders TN Veterinary University to Accept Transgender Candidate's Application - Law Trend
Don't reject transgender's application over identity HC tells TN veterinary varsity - The Week
Madras High Court Upholds Transgender Rights for Veterinary Course Admissions - Devdiscourse
Volato Facing Class-action WARN Act Lawsuit - Aviation International News
VolitionRx offers oncology assets for licensing - Investing.com India
VolitionRx offers oncology assets for licensing By Investing.com - Investing.com Australia
Volition Announces Board of Directors - TechBuzz News
CRYPTOPSY's New Shirts Are Very Serious - Metal Injection
Terminated Volato Employees File Class Action Lawsuit - FLYING
LifeLabs workers in GTA poised to strike if deal not reached by Saturday - CP24
Investing in VolitionRX Ltd (VNRX): What You Must Know - Knox Daily
Volition Hosts KOL Roundtable on Sepsis - Yahoo Finance
VolitionRX Ltd [VNRX] Records 200-Day SMA of $0.7821 - Knox Daily
The Potential Rise in the Price of VolitionRX Ltd (VNRX) following insiders activity - Knox Daily
VNRX: Nu.Q Vet Test is now available in 17 countries. Cost cutting continues in a plan to be cash flow neutral in 2025. Management focused on signing licensing deals for Capture-PCR (human cancer detection method) and Nu.Q NET for sepsis. $7.0 million fi - Yahoo Finance
Understanding the Risks of Investing in VolitionRX Ltd (VNRX) - Knox Daily
Comparing OncoCyte (NASDAQ:OCX) & VolitionRx (NYSE:VNRX) - Defense World
VolitionRx (NYSEAMERICAN:VNRX) Stock Price Passes Above 50-Day Moving Average of $0.00 - Defense World
VolitionRx Limited (NYSE:VNRX) Director Guy Archibald Innes Purchases 150,000 Shares - Defense World
VolitionRX Ltd (VNRX) Q2 2024 Earnings Call Transcript Highlight - GuruFocus.com
Benchmark Reiterates Hold Rating for VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Limited (AMEX:VNRX) Q2 2024 Earnings Call Transcript - Insider Monkey
Earnings call: VolitionRx reports strong growth and optimistic outlook - Investing.com
VolitionRX: Q2 Earnings Snapshot - San Antonio Express-News
Market Highlights: VolitionRX Ltd (VNRX) Ends on a Low Note at 0.53 - The Dwinnex
Form 424B5 VOLITIONRX LTD - StreetInsider.com
SEC Form 424B5 filed by VolitionRX Limited - Quantisnow
VolitionRx announces $7 million stock and warrant sale - Investing.com India
VolitionRx (NYSEAMERICAN:VNRX) Share Price Passes Above 50 Day Moving Average of $0.00 - Defense World
VNRX Stock Touches 52-Week Low at $0.55 Amid Market Challenges - Investing.com
VolitionRx (NYSEAMERICAN:VNRX) Shares Pass Above Fifty Day Moving Average of $0.00 - Defense World
Q1 2025 Adani Energy Solutions Ltd Earnings Call Transcript - Stockxpo
VolitionRx (NYSE:VNRX) Coverage Initiated by Analysts at StockNews.com - Defense World
Head And Neck Cancer Diagnostics Market Growth Analysis With Investment Opportunities - EIN News
Virax Biolabs Group (NASDAQ:VRAX) & VolitionRx (NYSE:VNRX) Head-To-Head Review - Defense World
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing - StockTitan
Envela Corp shareholders elect board, ratify auditor By Investing.com - Investing.com India
VolitionRx expands stock plan and authorized shares By Investing.com - Investing.com India
StockNews.com Initiates Coverage on VolitionRx (NYSE:VNRX) - Defense World
VolitionRx Provides a Business Update and Appoints Key Officers to Drive Commercialization Efforts - Quantisnow
VolitionRx Limited Issues Mid-Year Review Ahead of 2024 Annual Meeting - StockTitan
Volition's Nu.Q® Vet Cancer Test Now Available for Pre-Order at The Point-of-Care Through Heska Corporation - Quantisnow
Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network - Quantisnow
Volition Appoints Mickie Henshall as an Independent Director - Quantisnow
Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar - Quantisnow
Volition and Fujifilm Vet Systems Launch Nu.Q® Vet Cancer Test in Japan - Quantisnow
VolitionRx Limited Announces Full Fiscal Year 2023 Financial Results and Business Update - Quantisnow
Head-To-Head Analysis: Virax Biolabs Group (NASDAQ:VRAX) versus VolitionRx (NYSE:VNRX) - Defense World
Stock Market Recap: VolitionRX Ltd (VNRX) Concludes at 0.66, a -4.21 Surge/Decline – DWinneX - The Dwinnex
VolitionRx Limited Announces Second Quarter 2023 Financial Results and Business Update - Quantisnow
Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Yahoo Finance
3.48%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Capitalizzazione:
|
Volume (24 ore):